Picato: Clinical Trials

11 trials of Picato, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 withdrawn, 1 unknown. 3 Phase 4, 2 Phase 2, 1 Early Phase 1, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Unknown 1
Phase 22Completed 1, Withdrawn 1
Early Phase 11Withdrawn 1
Not applicable1Completed 1
Phase 11Withdrawn 1
Phase 31Completed 1

Follow Picato: new trials by email Literature Review of Picato trials Research Report on Picato

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment
Ingenol mebutate gel - Actinic Cheilitis
Phase 1 / Phase 2WithdrawnInstituto Nacional de Cancer, Brazil2020-02-012019-06-19
Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients
Picato - Molluscum Contagiosum
Early Phase 1WithdrawnCenter for Clinical Studies, Texas2017-12-202022-04-01
Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy
Ingenol mebutate, cryotherapy - Actinic Keratosis
Phase 4CompletedUniversity of Campania Luigi Vanvitelli502017-04-122019-09-24
Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
ingenol mebutate gel 0.015% - Actinic Keratosis
Phase 4CompletedUniversity of California, San Francisco202016-10-062022-03-09
The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice
Ingenol mebutate - Actinic Keratosis
CompletedLEO Pharma4402015-12-012019-01-22
Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts
Picato - Anogenital Warts
Phase 2CompletedLEO Pharma402015-02-012025-02-24
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Ingenol Mebutate (Picato®), Generic Ingenol Mebutate, Vehicle Foam - Actinic Keratosis
Phase 3CompletedActavis Inc.4412015-02-012020-05-12
IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
Imiquimod, 5-fluorouracil, Ingenol mebutate - Keratosis, Actinic
Phase 4UnknownMaastricht University Medical Center6242014-11-012017-10-30
The Real Life Topical Field Treatment of Actinic Keratosis Study
Ingenol mebutate, 5-fluorouracil, Imiquimod - Actinic Keratosis
CompletedLEO Pharma11682014-07-012019-12-13
Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis
ingenol mebutate, 5% 5-FU - Actinic Keratosis
Not applicableCompletedUniversity of Sao Paulo1002014-05-012014-09-17
TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction
Ingenol mebutate - Actinic Keratosis
CompletedLEO Pharma12182014-04-012023-06-09

Conditions studied

Keratosis, Actinic (8)  ·  Actinic cheilitis (1)  ·  Condylomata Acuminata (1)  ·  Molluscum Contagiosum (1)

Sponsors

LEO Pharma (4)  ·  Actavis Inc. (1)  ·  Center for Clinical Studies, Texas (1)  ·  Instituto Nacional de Cancer, Brazil (1)  ·  Maastricht University Medical Center (1)  ·  University of California, San Francisco (1)  ·  University of Campania Luigi Vanvitelli (1)  ·  University of Sao Paulo (1)

Countries

United States (3)  ·  Netherlands (2)  ·  Brazil (1)  ·  Denmark (1)  ·  Greece (1)  ·  Italy (1)

Top investigators

Daniel Cohen Goldemberg, PhD (1)  ·  Giuseppe Argenziano, Prof (1)  ·  Klara Mosterd, MD, PhD (1)  ·  Kostas Sitaras, MD (1)  ·  Luis Antonio Torezan, PhD (1)  ·  Oleg Khatsenko, Ph.D (1)  ·  Sarah Arron, MD, PhD (1)  ·  Sarah Moumane, MD (1)  ·  Stephen K Tyring, MD, PhD (1)

Results publications

PMID 11966728, PMID 12533168, PMID 15168956, PMID 18067627, PMID 20231500, PMID 20725550, PMID 24672213, PMID 25727104, PMID 30855743, PMID 31961446, PMID 33476658, PMID 35475852, PMID 7947197

NIH funding

2014 (1)